ENO2 and neoplasm: Given the patient’s progressive clinical deterioration despite adequate antibiotic therapy, elevated tumor markers (CYFRA21-1, NSE, CEA, SCC), and the concerning pattern of enlarging cavities, PET/CT was performed to assess the metabolic activity of the lesions and to provide additional information for guiding further diagnostic steps.